PharmaTimes

FEBRUARY 14, 2024

The report includes five recommendations for the government to address these issues

Government 89

Government Medical science Medical 89

pharmaphorum

DECEMBER 23, 2022

Seamless data sharing between clinical teams and medical science liaisons, for example, could greatly influence clinical trial site selection and ensure more coordinated engagement. Medical’s existing data silos and the need for stronger data governance will add to the challenge.

Marketing 96

Marketing Sales Medical Patients 96

Clarivate

JUNE 21, 2022

The massive and rapid response of the scholarly community to COVID-19 extends far beyond medical care or medical sciences, and its ripples will continue for years, or decades. COVID-19 and the ramifications of its spread were entirely novel topics of study and have changed the landscape of scholarly publishing.

Prospecting 138

Prospecting Medical science Medicine Distribution 138

Impetus Digital

APRIL 24, 2023

Piliero predicted several major change points for Medical Science Liaisons (MSLs), including: MSLs will engage a broader range of external stakeholders beyond traditional physicians, including nurses, physician assistants, patients, academics, payers and policymakers, and digital opinion leaders (DOLs).

Medical 52

Medical Education Physicians Healthcare 52

Pharmaceutical Technology

JULY 10, 2008

With it currently taking ten to 12 years and up to £550m to get a medicine through testing and approval, he says the UK is effectively turning its back on the most recent developments in medical sciences. “It’s very disappointing. “There is a real threat the pharmaceutical R&D industry could move offshore.”

Food and Drug Administration 52

Food and Drug Administration Medicine Pharmaceutical Government 52

Clarivate

AUGUST 2, 2023

The study indicates that 20% of researchers use five or more different profile platforms simultaneously, adding to their administrative load.

Networking 98

Networking Medical science Management Leads 98